Czechia· CZ-0500795
TRACTOCILE
A atosiban product containing atosiban acetate, registered in Czechia by Ferring Pharmaceuticals A/S, Kastrup. The same ATC class is registered in 14 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Atosiban is registered in 14 of 19 countries.
Countries holding a registration under ATC G02CX01 (atosiban), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Atosiban · ATC G02CX01
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
SÚKL (Czech Republic)- Active substance
- ATOSIBAN ACETATE
- Manufacturer
- Ferring Pharmaceuticals A/S, Kastrup
- Country
- Czechia (CZ)
- ATC code
- G02CX01
- ATC class
- Atosiban
- Defined daily dose
- 165 mg, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl05007951X0,9MLCZK 807.67
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Atosiban in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainATOSIBAN ACCORD 6,75 MG /0,9 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA EFGAccord Healthcare S.L.U.
- BelgiumAtosiban Altan 6.75 mg/0.9 mlAltan Pharma
- PolandAtosiban AccordAccord Healthcare Polska Sp. z o.o.
- SwedenAtosiban EVER Pharma 6,75 mg/0,9 ml Injektionsvätska, lösningEVER Valinject GmbH
- IcelandAtosiban SUNSun Pharmaceutical Industries Europe B.V.*
- NorwayAtosiban SUNSun Pharmaceutical - Nederland
- SwitzerlandAtosiban Labatec 6.75 mg / 0.9 ml, solution injectableLabatec Pharma SA
- FinlandAtosiban StragenStragen Nordic A/S
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Atosiban Altan, Atosiban Ever Pharma
- Belgium · Atosiban Ever Pharma
- Bulgaria · Атозибан Ever Pharma
- Germany · Atosiban Ever Pharma, Atosiban Ibisqus
- Denmark · Atosiban Ever Pharma
- Spain · Atosiban Altan Pharmaceuticals, S.A., Atosiban Ever Pharma
- Finland · Atosiban Ever Pharma
- France · Atosiban Altan, Atosiban Altan Pharmaceuticals, S.A.
- United Kingdom (Northern Ireland) · Atosiban Ibigen
- Greece · Atosiban Ever Pharma
- Croatia · Atosiban Ever Pharma, Atosiban Makpharm
- Iceland · Atosiban Sun, Tractocile
- Italy · Atosiban Ever Pharma, Atosiban Ibisqus
- Liechtenstein · Tractocile
- Luxembourg · Atosiban Ever Pharma
- Latvia · Atosiban Pharmidea
- Netherlands · Atosiban Accord, Atosiban Ever Pharma
- Norway · Atosiban Ever Pharma, Atosiban Sun
- Poland · Atosiban Ever Pharma
- Portugal · Atosiban Ever Pharma, Atosibano Altan
- Sweden · Atosiban Accord, Atosiban Ever Pharma
- Slovenia · Atoziban Ever Pharma
- Slovakia · Atosiban Ardez
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c9d2a9fe-b0df-413d-946d-c5c7cafc7fbc GET /v1/drugs/c9d2a9fe-b0df-413d-946d-c5c7cafc7fbc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL",
"source": "sukl",
"strength": "6,75MG/0,9ML",
"pack_size": "1X0,9ML",
"substance": "ATOSIBAN ACETATE",
"cz_kod_sukl": "0500795",
"product_type": "CH",
"substance_codes": "16171",
"registration_state": "R",
"registration_number": "EU/1/99/124/001"
}See everything about atosiban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.